Recent advances in metabonomics

Acta Academiae Medicinae Sinicae

Volumn 29, Issue 6, 2007, Pages 701-711

  Xu, Guo Wang ^a   Lu, Xin ^a   Yang, Sheng Li ^a  

^a DALIAN INSTITUTE OF CHEMICAL PHYSICS   (China)

Author keywords

Mass spectrometay; Metabolomics; Metabonomics; System biology

Indexed keywords

BIOLOGICAL MARKER;

ANALYTIC METHOD; EDITORIAL; FUNCTIONAL GENOMICS; GENOMICS; MASS SPECTROMETRY; METABOLITE; METABOLOMICS; MOLECULAR DYNAMICS; PATHOLOGY; PLANT; PROTEOMICS; QUANTITATIVE ANALYSIS; SYSTEMS BIOLOGY; TRANSCRIPTOMICS;

BIOLOGICAL MARKERS; DRUG DISCOVERY; METABOLOME; METABOLOMICS;

EID: 38849175481     PISSN: 1000503X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (103)

1. Nicholson JK, Lindon JC, Holmes E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data [J]. Xenobiotica, 1999, 29(11):1181-1189.
2. Fiehn O, Kopka J, Dormann P, et al. Metabolite profiling for plant functional genomics [J]. Nat Biotechnol, 2000, 18(11):1157-1161.
3. Gates SC, Sweeley CC. Quantitative metabolic profiling based on gas chromatography [J]. Clin Chem, 1978, 24 (10):1663-1673.
4. van der Greef J, Leegwater DC. Urine profile analysis by field desorption mass spectrometry, a technique for detecting metabolites of xenobiotics. Application to 3, 5-dinitro-2-hydroxytoluene [J]. Biomed Mass Spectrom, 1983, 10 (1):1-4.
5. Brindle JT, Antti H, Holmes E, et al. Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using H-1-NMR-based metabonomics [J]. Nat Med, 2002, 8(12):1439-1444.
6. Oliver SG. From gene to screen with yeast [J]. Curr Opin Genet Dev, 1997, 7(3):405-409.
7. Field D, Sansone SA. A special issue on data standards [J]. Omics, 2006, 10(2):84-93.
8. Fiehn O, Kristal B, Van Ommen B, et al. Establishing reporting standards for metabolomic and metabonomic studies: a call for participation [J]. Omics, 2006, 10(2): 158-163.
9. Lindon JC, Nicholson JK, Holmes E, et al. Summary recommendations for standardization and reporting of metabolic analyses [J]. Nat Biotechnol, 2005, 23(7):833-838.
10. Dettmer K, Aronov PA, Hammock BD. Mass spectrometry-based metabolomics [J]. Mass Spectrom Rev, 2007, 26(1):51-78.
11. Ackermann BL, Hale JE, Duffin KL. The role of mass spectrometry in biomarker discovery and measurement [J]. Curr Drug Metab, 2006, 7(5):525-539.
12. Dunn WB, Ellis DI. Metabolomics: current analytical platforms and methodologies [J]. Truc Trends Anal Chem, 2005, 24(4):285-294.
13. Hollywood K, Brison DR, Goodacre R. Metabolomics: current technologies and future trends [J]. Proteomics, 2006, 6(17):4716-4723.
14. Dunn WB, Bailey NJC, Johnson HE. Measuring the metabolome: current analytical technologies [J]. Analyst, 2005, 130(5):606-625.
15. Yang J, Xu GW, Zheng YF, et al. Diagnosis of liver cancer using HPLC-based metabonomics avoiding false-positive result from hepatitis and hepatocirrhosis diseases [J]. J Chromatogr B, 2004, 813(1-2):59-65.
16. Govil G. Metabonomics: a new frontier of nuclear magnetic resonance (NMR) [J]. Natl Acad Sci Lett India, 2004, 27(9-10):289-299.
17. Ramautar R, Demirci A, de Jong GJ. Capillary electrophoresis in metabolomics [J]. Trac Trends Anal Chem, 2006, 25(5):455-466.
18. Britz-McKibbin P, Terabe S. On-line preconcentration strategies for trace analysis of metabolites by capillary electrophoresis [J]. J Chromatogr A, 2003, 1000(1-2):917-934.
19. Lasch P, Boese M, Pacifico A, et al. FT-IR spectroscopic investigations of single cells on the subcellular level [J]. Vib Spectrosc, 2002, 28(1):147-157.
20. Schmitt J, Beekes M, Brauer A, et al. Identification of scrapie infection from blood serum by Fourier transform infrared spectroscopy [J]. Anal Chem, 2002, 74(15): 3865-3868.
21. Gamache PH, Meyer DF, Granger MC, et al. Metabolomic applications of electrochemistry/mass spectrometry [J]. J Am Soc Mass Spectrom, 2004, 15(12):1717-1726.
22. Daykin CA, Corcoran O, Hansen SH, et al. Application of directly coupled HPLC MMR to separation and characterization of lipoproteins from human serum [J]. Anal Chem, 2001, 73(6):1084-1090.
23. Krishnan P, Kruger NJ, Ratcliffe RG. Metabolite finger-printing and profiling in plants using NMR [J]. J Exp Bot, 2005, 56(410):255-265.
24. Griffin JL, Walker LA, Garrod S, et al. NMR spectroscopy based metabonomic studies on the comparative biochemistry of the kidney and urine of the bank vole (Clethrionomys glareolus), wood mouse (Apodemus sylvaticus), white toothed shrew (Crocidura suaveolens) and the laboratory rat [J]. Comp Biochem Physiol B Biochem Mol Biol, 2000, 127(3):357-367.
25. Griffin JL, Bollard ME. Metabonomics: its potential as a tool in toxicology for safety assessment and data integration [J]. Curr Drug Metab, 2004, 5(5):389-398.
26. Griffin JL. Metabonomics: NMR spectroscopy and pattern recognition analysis of body fluids and tissues for characterisation of xenobiotic toxicity and disease diagnosis [J]. Curr Opin Chem Biol, 2003, 7(5):648-654.
27. Pelczer I. High-resolution NMR for metabomics [J]. Curr Opin Drug Discov Dev, 2005, 8(1):127-133.
28. Gavaghan CL, Holmes E, Lenz E, et al. An NMR-based metabonomic approach to investigate the biochemical consequences of genetic strain differences: application to the C57BL10J and Alpk: ApfCD mouse [J]. FEBS Lett, 2000, 484(3):169-174.
29. Holmes E, Nicholson JK, Tranter G. Metabonomic characterization of genetic variations in toxicological and metabolic responses using probabilistic neural networks [J]. Chem Res Toxicol, 2001, 14(2):182-191.
30. Jones G, Sang E, Goddard C, et al. A functional analysis of mouse models of cardiac disease through metabolic profiling [J]. J Biol Chem, 2005, 280(9):7530-7539.
31. Marchesi JR, Holmes E, Khan F, et al. Rapid and noninvasive metabonomic characterization of inflammatory bowel disease [J]. J Proteome Res, 2007, 6(2):546-551.
32. Glinski M, Weckwerth W. The role of mass spectrometry in plant systems biology [J]. Mass Spectrom Rev, 2006, 25(2):173-214.
33. Denkert C, Budczies J, Kind T, et al. Mass spectrometry-based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors [J]. Cancer Res, 2006, 66(22):10795-10804.
34. Styczynski MP, Moxley JF, Tong LV, et al. Systematic identification of conserved metabolites in GC/MS data for metabolomics and biomarker discovery [J]. Anal Chem, 2007, 79(3):966-973.
35. Lenz EM, Wilson ID. Analytical strategies in metabonomics [J]. J Proteome Res, 2007, 6(2):443-458.
36. Wilson ID, Plumb R, Granger J, et al. HPLC-MS-based methods for the study of metabonomics [J]. J Chromatogr B, 2005, 817(1):67-76.
37. Yang J, Zhao XJ, Liu XL, et al. High performance liquid chromatography-mass spectrometry for metabonomics: potential biomarkers for acute deterioration of liver function in chronic hepatitis B [J]. J Proteome Res, 2006, 5(3): 554-561.
38. Wagner S, Scholz K, Sieber M, et al. Tools in metabonomics: an integrated validation approach for LC-MS metabolic profiling of mercapturic acids in human urine [J]. Anal Chem, 2007, 79(7):2918-2926.
39. Bajad SU, Lu WY, Kimball EH, et al. Separation and quantitation of water soluble cellular metabolites by hydrophilic interaction chromatography-tandem mass spectrometry [J]. J Chromatogr A, 2006, 1125(1):76-88.
40. Yin PY, Zhao XJ, Li QR, et al. Metabonomics study of intestinal fistulas based on ultraperformance liquid chromatography coupled with Q-TOF mass spectrometry (UPLC/Q-TOF MS) [J]. J Proteome Res, 2006, 5(9):2135-2143.
41. Plumb RS, Johnson KA, Rainville P, et al. The detection of phenotypic differences in the metabolic plasma profile of three strains of Zucker rats at 20 weeks of age using ultra-performance liquid chromatography/orthogonal acceleration time-of-flight mass spectrometry [J]. Rapid Commun Mass Spectrom, 2006, 20(19):2800-2806.
42. Granger J, Plumb R, Castro-Perez J, et al. Metabonomic studies comparing capillary and conventional HPLC-oa-TOF MS for the analysis of urine from Zucker obese rats [J]. Chromatographia, 2005, 61(7-8):375-380.
43. Oikawa A, Nakamura Y, Ogura T, et al. Clarification of pathway-specific inhibition by Fourier transform ion cyclotron resonance/ mass spectrometry-based metabolic phenotyping studies [J]. Plant Physiol, 2006, 142(2): 398-413.
44. Chinese source.
45. Chinese source.
46. Chinese source.
47. Beckwith-Hall BM, Brindle JT, Barton RH, et al. Application of orthogonal signal correction to minimise the effects of physical and biological variation in high resolution H-1 NMR spectra of biofluids [J]. Analyst, 2002, 127(10): 1283-1288.
48. Mao HL, Xu M, Wang B, et al. Evaluation of filtering effects of orthogonal signal correction on metalmonomic analysis of healthy human serum H-1 NMR spectra [J]. Acta Chim Sin, 2007, 65(2):152-158.
49. Nielsen NPV, Carstensen JM, Smedsgaard J. Aligning of single and multiple wavelength chromatographic profiles for chemometric data analysis using correlation optimised warping [J]. J Chromatogr A, 1998, 805(1-2):17-35.
50. Jonsson P, Gullberg J, Nordstrom A, et al. A strategy for identifying differences in large series of metabolomic samples analyzed by GC/MS [J]. Anal Chem, 2004, 76 (6):1738-1745.
51. Yang J, Xu GW, Zheng WF, et al. Strategy for metabonomics research based on high-performance liquid chromatography and liquid chromatography coupled with tandem mass spectrometry [J]. J Chromatogr A, 2005, 1084(1-2):214-221.
52. Oresic M, Vidal-Puig A, Hanninen V. Metabolomic approaches to phenotype characterization and applications to complex diseases [J]. Expert Rev Mol Diagn, 2006, 6 (4):575-585.
53. van Doorn M, Vogels J, Tas A, et al. Evaluation of metabolite profiles as biomarkers for the pharmacological effects of thiazolidinediones in type 2 diabetes mellitus patients and healthy volunteers [J]. Br J Clin Pharmacol, 2007, 63(5):562-574.
54. Morvan D, Demidem A. Metabolomics by proton nuclear magnetic resonance spectroscopy of the response to chloro-ethylnitrosourea reveals drug efficacy and tumor adaptive metabolic pathways [J]. Cancer Res, 2007, 67(5): 2150-2159.
55. Weljie AM, Newton J, Mercier P, et al. Targeted profiling: quantitative analysis of H-1 NMR metabolomics data [J]. Anal Chem, 2006, 78(13):4430-4442.
56. Holmes E, Antti H. Chemometric contributions to the evolution of metabonomics: mathematical solutions to characterising and interpreting complex biological NMR spectra [J]. Analyst, 2002, 127(12):1549-1557.
57. Keun HC, Ebbels TMD, Bollard ME, et al. Geometric trajectory analysis of metabolic responses to toxicity can define treatment specific profiles [J]. Chem Res Toxicol, 2004, 17(5):579-587.
58. Lutz U, Lutz RW, Lutz WK. Metabolic profiling of glucuronides in human urine by LC-MS/MS and partial least-squares discriminant analysis for classification and prediction of gender [J]. Anal Chem, 2006, 78(13):4564-4571.
59. Holmes E, Nicholls AW, Lindon JC, et al. Chemometric models for toxicity classification based on NMR spectra of biofluids [J]. Chem Res Toxicol, 2000, 13(6):471-478.
60. Wang C, Kong HW, Guan YF, et al. Plasma phospholipid metabolic profiling and biomarkers of type 2 diabetes mellitus based on high-performance liquid chromatography/electrospray mass spectrometry and multivariate statistical analysis [J]. Anal Chem, 2005, 77(13):4108-4116.
61. Teahan O, Gamble S, Holmes E, et al. Impact of analytical bias in metabonomic studies of human blood serum and plasma [J]. Anal Chem, 2006, 78(13):4307-4318.
62. Craig A, Cloareo O, Holmes E, et al. Scaling and normalization effects in NMR spectroscopic metabonomic data sets [J]. Anal Chem, 2006, 78(7):2262-2267.
63. van den Berg RA, Hoefsloot HCJ, Westerhuis JA, et al. Centering, scaling, and transformations: improving the biological information content of metabolomics data [J]. BMC Genomics, 2006, 7:15.
64. Robertson DG, Reily MD, Baker JD. Metabonomics in pharmaceutical discovery and development [J]. J Proteome Res, 2007, 6(2):526-539.
65. Keun HC. Metabonomic modeling of drug toxicity [J]. Pharmacol Ther, 2006, 109(1-2):92-106.
66. Kell DB. Systems biology, metabolic modelling and metabolomics in drug discovery and development [J]. Drug Discov Today, 2006, 11(23-24):1085-1092.
67. Lindon JC, Holmes E, Nicholson JK. Metabonomics and its role in drug development and disease diagnosis [J]. Expert Rev Mol Diagn, 2004, 4(2):189-199.
68. Craig A, Sidaway J, Holmes E, et al. Systems toxicology: integrated genomic, proteomic and metabonomic analysis of methapyrilene induced hepatotoxicity in the rat [J]. J Proteome Res, 2006, 5(7):1586-1601.
69. Waters NJ, Holmes E, Waterfield CJ, et al. NMR and pattern recognition studies on liver extracts and intact livers from rats treated with alpha-naphthylisothiocyanate [J]. Biochem Pharmacol, 2002, 64(1):67-77.
70. Lindon JC, Keun HC, Ebbels TMD, et al. The consortium for metabonomic toxicology (COMET): aims, activities and achievements [J]. Pharmacogenomics, 2005, 6(7): 691-699.
71. Lindon JC, Nicholson JK, Holmes E, et al. Contemporary issues in toxicology-the role of metabonomics in toxicology and its evaluation by the COMET project [J]. Toxicol Appl. Pharmacol, 2003, 187(3):137-146.
72. Mally A, Amberg A, Hard GC, et al. Are 4-hydroxy-2 (E) -nonenal derived mercapturic acids and H-1 NMR metabonomics potential biomarkers of chemically induced oxidative stress in the kidney [J]? Toxicology, 2007, 230 (2-3):244-255.
73. Bowser R, Cudkowicz M, Kaddurah-Daouk H. Biomarkers for amyotrophic lateral sclerosis [J]. Expert Rev Mol Diagn, 2006, 6(3):387-398.
74. Griffin JL. Understanding mouse models of disease through metabolomics [J]. Curr Opin Chem Biol, 2006, 10(4): 309-315.
75. Schnackenberg LK, Beger RD. Monitoring the health to disease continuum with global metabolic profiling and systems biology [J]. Pharmacogenomics, 2006, 7(7):1077-1086.
76. Pan ZZ, Gu HW, Talaty N, et al. Principal component analysis of urine metabolites detected by NMR and DESI-MS in patients with inborn errors of metabolism [J]. Anal Bioanal Chem, 2007, 387(2):539-549.
77. Kuhara T. Gas chromatographic-mass spectrometric urinary metabolome analysis to study mutations of inborn errors of metabolism [J]. Mass Spectrom Rev, 2005, 24(6):814-827.
78. Fava F, Lovegrove JA, Gitau R, et al. The gut microbiota and lipid metabolism: implications for human health and coronary heart disease [J]. Curr Med Chem, 2006, 13 (25):3005-3021.
79. Van QN, Klose JR, Lucas DA, et al. The use of urine proteomic and metabonomic patterns for the diagnosis of interstitial cystitis and bacterial cystitis [J]. Dis Markers, 2003, 19(4-5):169-183.
80. Brindle JT, Nicholson JK, Schofield PM, et al. Application of chemometrics to H-1 NMR spectroscopic data to investigate a relationship between human serum metabolic profiles and hypertension [J]. Analyst, 2003, 128(1): 32-36.
81. Yao JK, Reddy RD. Metabolic investigation in psychiatric disorders [J]. Mol Neurobiol, 2005, 31(1-3):193-203.
82. Jia LW, Wang C, Kong HW, et al. Effect of PA-MSHA vaccine on plasma phospholipids metabolic profiling and the ratio of Th2/Th1 cells within immune organ of mouse IgA nephropathy [J]. J Pharm Biomed Anal, 2007, 43 (2):646-654.
83. Zhao XJ, Wang WZ, Wang JS, et al. Urinary profiling investigation of metabolites with cis-diol structure from cancer patients based on UPLC-MS and HPLC-MS as well as multivariate statistical analysis [J]. J Sep Sci, 2006, 29 (16):2444-2451.
84. Yang J, Xu GW, Hong QF, et al. Discrimination of type 2 diabetic patients from healthy controls by using metabonomics method based on their serum fatty acid profiles [J]. J Chromatogr B, 2004, 813(1-2):53-58.
85. Jia LW, Wang C, Kong HW, et al. Plasma phospholipid metabolic profiling and biomarkers of mouse IgA nephropathy [J]. Metabolomics, 2006, 2(2):95-104.
86. Yuan KL, Kong HW, Guan YF, et al. A GC-based metabonomics investigation of type 2 diabetes by organic acids metabolic profile [J]. J Chromatogr B, 2007, 850(1-2): 236-240.
87. Zheng YF, Xu GW, Yang J, et al. Determination of urinary nucleosides by direct injection and coupled-column high-performance liquid chromatography [J]. J Chromatogr B, 2005, 819(1):85-90.
88. Zheng YF, Kong HW, Xiong JH, et al. Clinical significance and prognostic value of urinary nucleosides in breast cancer patients [J]. Clin Biochem, 2005, 38(1):24-30.
89. Dixon RA, Gang DR, Charlton AJ, et al. Perspective-applications of metabolomics in agriculture [J]. J Agric Food Chem, 2006, 54(24):8984-8994.
90. Bino RJ, Hall RD, Fiehn O, et al. Potential of metabolomics as a functional genomics tool [J]. Trends Plant Sci, 2004, 9(9):418-425.
91. Fiehn O. Metabolic networks of cucurbita maxima phloem [J]. Phytochemistry, 2003, 62(6):875-886.
92. Ma C, Wang H, Lu X, et al. Analysis of Artemisia annua L. volatile oil by comprehensive two-dimensional gas chromatography time-of-flight mass spectrometry [J]. J Chromatogr A, 2007, 1150(1-2):50-53.
93. Ma C, Wang H, Lu X, et al. Metabolic fingerprinting investigation of Artemisia annua L. in different stages of development by gas chromatography and gas chromatography-mass spectrometry [J/OL]. J Chromatogr A, 2007, [2007-09-17]. http://www.ncbi.nlm.nih.gov/sites/ entrez?Db=puhmed&Cmd=ShowDetailView&TermToSearch= 17915234&ordinalpos=1&itool= EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum.
94. Elmroth I, Sundin P, Valeur A, et al. Evaluation of chromatographic methods for the detection of bacterial-contamination in biotechnical processes [J]. J Microbiol Methods, 1992, 15(3):215-228.
95. Bandy JG, Willey Th, Castell RS, et al. Discrimination of pathogenic clinical isolates and laboratorv strains of Bacillus cereus by NMR-based metabolomic profiling [J]. FEMS Microbiol Lett, 2005, 242(1):127-136.
96. Raamsdonk LM, Teusink B, Broadhurst D, et al. A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations [J]. Nat Biotechnol, 2001, 19(1):45-50.
97. Buchholz A, Hurlebaus J, Wandrey C, et al. Metabolomics: quantification of intracellular metabolite dynamics [J]. Biomol Eng, 2002, 19(1):5-15.
98. Andersen DC, Swartz J, Ryll T, et al. Metabolic oscillations in an E-coli fermentation [J]. Biotechnol Bioeng, 2001, 75(2):212-218.
99. Dauner M, Bailey JE, Sauer U. Metabolic flux analysis with a comprehensive isotopomer model in Bacillus subtilis [J]. Biotecbnol Bioeng, 2001, 76(2):144-156.
100. Dalluge JJ, Smith S, Sanchez-Riera F, et al. Potential of fermentation profiling via rapid measurement of amino acid metabolism by liquid chromatography-tandem mass spectrometry [J]. J Chromatogr A, 2004, 1043(1):3-7.
101. Boersma MG, Solyanikova IP, van Berkel WJH, et al. F-19 NMR metabolomics for the elucidation of microbial degradation pathways of fluorophenols [J]. J Ind Microbiol Biotechnol, 2001, 26(1-2):22-34.
102. Narasimhan K, Basheer C, Bajic VB, et al. Enhancement of plant-microbe interactions using a rhizosphere metabolomics-driven approach and its application in the removal of polychlorinated biphenyls [J]. Plant Physiol, 2003, 132 (1):146-153.
103. Gao P, Shi CY, Tian J, et al. Investigation on response of the metabolites in tricarboxylic acid cycle of Escherichi coli and Pseudomonas aeruginosa to antibiotic perturbation by capillary electrophoresis [J]. J Pharm Biomed Anal, 2007, 44(1):180-187.